Myeloproliferative Neoplasms
Ruben Mesa, MD, FACP
Selection and Sequencing of JAK Inhibitors and Other Emerging Agents for MPNs #BeyondASH21
More from Myeloproliferative Neoplasms
Michael Savona, MD
Recently Presented Data of Clinical Trials in Patients with MDS/MPNs #BeyondASH21